Skip to main content
Clinical Trials/NCT03339921
NCT03339921TerminatedPhase 2

Comparison of Botulinum Toxin to Fasciotomy in Treatment of Chronic Exertional Compartment Syndrome

375th Medical Group, Scott Air Force Base1 site in 1 country3 target enrollmentStarted: December 7, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Terminated
Sponsor
Enrollment
3
Locations
1
Primary Endpoint
Lower Extremity Functional Index

Study Overview

Brief Summary

We will investigate the feasibility of a simple outpatient one time injection regimen for the treatment of Chronic Exertional Compartment Syndrome (CECS). We think botulinum toxin injections will be a potentially cost-effective, low-risk alternative to surgery in reducing pain and returning patients to full activity.

Detailed Description

The study will be a prospective cohort pilot study designed to compare Active Duty patients, 18 years of age or older, with Chronic Exertional Compartment Syndrome (CECS) undergoing two different treatment interventions. The first arm will be patients receiving investigational botulinum toxin injections. The second arm will be patients who undergo the standard of care surgical fasciotomy. Both arms will be evaluated for pain relief with the universal pain scale and lower extremity functional index (LEFI) surveys at pre-treatment and again at one, three, and six months post-treatment. Clinical data that will be analyzed for research purposes in both groups include age, sex, height, weight, body mass index, time to diagnosis, minutes of exercise prior to onset of symptoms, minutes of rest before relief of symptoms, LEFI and pain on the Universal Pain Assessment Tool.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult ages 18-65
  • Active duty military
  • Unable to run 1.5 miles without producing symptoms, including aching, burning, numbness, tingling, or weakness in the affected limb
  • Failed conservative treatment over a period of 2 months, including trial of rest, NSAIDs, icing, and stretching routine
  • Meets standard of care clinical diagnostic intramuscular compartment pressure criteria for CECS, based on standardized IMP needle testing. See below for testing protocol and criteria.

Exclusion Criteria

  • Prior Botulinum toxin injections into the affected limb
  • Prior compartment release of the affected limb
  • Pregnant or becomes pregnant during the study
  • Standard of care clinical exams indicating other more likely causes of leg pain

Arms & Interventions

Botulinum toxin injections

Experimental

Botulinum toxin injections for chronic compartment syndrome

Intervention: Botulinum toxin injections for chronic compartment syndrome (Drug)

surgical fasciotomy

Active Comparator

surgical fasciotomy for chronic compartment syndrome

Intervention: surgical fasciotomy for chronic compartment syndrome (Procedure)

Outcomes

Primary Outcomes

Lower Extremity Functional Index

Time Frame: 6 months

The Lower Extremity Functional Index measures the functional impairment of a patient with a lower extremity disorder. It can be used to monitor the patient over time and to evaluate the effectiveness of an intervention. Score ranges from 0 to 80. Lower scores indicate more functional impairment.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
375th Medical Group, Scott Air Force Base
Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials